-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Integrated Biopharma Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q4 2020 to Q1 2022.
- Integrated Biopharma Inc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2022 was $49K, a 47.9% decline year-over-year.
- Integrated Biopharma Inc annual Share-based Payment Arrangement, Expense for 2021 was $231K, a 292% increase from 2020.
- Integrated Biopharma Inc annual Share-based Payment Arrangement, Expense for 2020 was $59K, a 59% decline from 2019.
- Integrated Biopharma Inc annual Share-based Payment Arrangement, Expense for 2019 was $144K, a 929% increase from 2018.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)